News

The latest press releases, publications, and events for Innoviva Specialty Therapeutics

Filter by:

All News Press Releases Events

01.22.2025

Zoliflodacin: Addressing a growing global threat through a novel public-private development partnership

Read More

01.22.2025

Oral zoliflodacin is non-inferior to a combination of ceftriaxone and azithromycin for treatment of uncomplicated urogenital gonorrhoea: Results of a large global Phase 3 randomised controlled trial

Read More

01.22.2025

Oral zoliflodacin for treatment of uncomplicated gonorrhea Subgroup analyses by sex at birth, race and region of a global Phase 3 randomized controlled clinical trial

Read More

01.22.2025

Recommendations for the optimal introduction of novel antibiotics to treat uncomplicated gonorrhoea in the face of increasing antimicrobial resistance: a case study with zoliflodacin

Read More

01.22.2025

Descriptive analysis of sexually transmitted infections risk factors among participants included in the global zoliflodacin Phase 3 clinical trial

Read More

01.22.2025

In Vitro Activity of Zoliflodacin against Contemporary Neisseria gonorrhoeae isolate from the United States

Read More

12.11.2024

Oral zoliflodacin is non-inferior to a combination of ceftriaxone and azithromycin for treatment of uncomplicated urogenital gonorrhoea: results of a large global Phase 3 randomised controlled trial

Read More

11.19.2024

Pharmacometric Analyses to Support Dose Selection of Zoliflodacin, a First-in-Class Oral Antibiotic Being Developed for the Treatment of Uncomplicated Gonorrhea

Read More

09.17.2024

Interactions between Zoliflodacin and Neisseria gonorrhoeae Gyrase and Topoisomerase IV: Enzymological Basis for Cellular Targeting.

Read More

06.11.2024

Pharmacokinetics of zoliflodacin in healthy participants in the presence of itraconazole suggest no clinically meaningful CYP3A4-mediated drug-drug interactions

Read More